Anthracyclines Improve Survival In HER2-positive Breast Cancer Patients
Treatment with the class of chemotherapy drugs called anthracyclines improves survival in women with HER2-positive breast cancer who have previously had surgery, but it may not offer any benefit for women with HER2-negative tumors, according to a study published online December 25 in the Journal of the National Cancer Institute. [click link for full article]
More: continued here
Filed under: Breast Cancer on December 29th, 2007